FDA warns Argon Medical over dental implant quality-system failures, unreported injuries, and missing unique device identifier labeling.
What happened
During a July 29–31, 2024 inspection in Bingen am-Rhein, Germany, FDA found that Argon Medical's dental implant manufacturing and quality controls did not meet current good manufacturing practice/quality system regulation requirements. FDA also found that complaints of dental implant osseointegration failure were not investigated or reported as serious injuries, that medical device reporting procedures were deficient, and that required unique device identifier labeling and database information were missing.
What FDA found
The firm did not investigate a complaint about dental implant osseointegration failure and did not document why no investigation was needed.
21 CFR 820.198(c)The firm's written medical device reporting procedure did not define reportable events or ensure timely, complete reports.
21 CFR 803.17(a), 803.17(a)(1), 803.17(a)(3)The firm did not submit 30-day reports for three patients whose dental implants failed to integrate.
21 CFR 803.50(a)(1)Labels for several K3Pro dental implants lacked the required unique device identifier in plain text and/or machine-readable form.
21 CFR 801.20(a), 801.40(a)(1), 801.40(a)(2)The firm did not submit required unique device identifier information to FDA's GUDID database.
21 CFR 830.300(a), 830.320(b)
What FDA wants
FDA tells the firm to reply in writing within 15 business days with the specific steps taken, supporting documentation, a timetable for planned actions, and English translations of documents not in English.
Who should pay attention
- dental implant distributors and clinicians
- companies relying on complaint and medical device reporting systems
- labelers that must submit unique device identifier data to GUDID
This is a summary. Read the original letter on fda.gov.